| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1965287bbf129f30b9d4f95fc17c72f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2635de57668d3c06a60879a354fd248f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd44f60f1f7e9bdd9b3ea57449bf1886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d53b8ecfd86d03daf3a9d8514abc351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c58fbed9ff9ac70dcd180c029bfb499c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b2198b3e1c7e440e48ba021024f336c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b3126ce9363bd923fdac7a72b31612e |
| publicationDate |
2016-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2956854-A1 |
| titleOfInvention |
Competitive ppar-gamma antagonists |
| abstract |
The present invention pertains to a new compound E)-2-(5-((4-methoxy-2- (trifluoromethyl)quinolin-6-yl)methoxy)-2-((4-(trifluoromethyl) benzyl)oxy)-benzylidene) hexanoic acid (MTTB), and its derivatives. The compounds of the invention are useful as selective peroxisome proliferator-activated receptor gamma (PPAR) antagonists and are indicated for the use in the treatment of immune related diseases such as systemic inflammation, sepsis and septic shock. |
| priorityDate |
2014-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |